The degree of histone lysine Kla has been found to be higher in TAM than in other tissues, implying that Kla plays an important regulatory role in TME, which may provide a new direction for tumor immunotherapy, antiangiogenesis therapy, and targeted therapy. This evidence concerns the gene KL and neoplasm.